Type 1 Diabetes

New advances in diabetes technology are moving beyond glucose alone. While continuous glucose monitoring transformed diabetes management over the last decade, wearable ketone monitoring systems are now emerging as the next major innovation. Researchers, device manufacturers, and international diabetes organizations are increasingly focused on whether real-time ketone data can help …

A patient arrives at the pharmacy expecting their usual insulin refill, only to discover the box, brand name, and pen device suddenly look different. The pharmacist explains that the medication is an interchangeable biosimilar approved for automatic substitution. Although the insulin is considered clinically equivalent, the unexpected switch can still …

Can we actually prevent type 1 diabetes before symptoms appear? Increasingly, the answer is yes. As research evolves, clinicians now have stronger tools to identify at-risk children earlier and delay disease progression. This shift is especially important because type 1 diabetes often develops silently before diagnosis. Therefore, early screening and …

Can a chronic condition like type 1 diabetes be slowed before it fully develops? Recent long-term studies suggest that preventing or delaying type 1 diabetes may be closer to reality than once believed. In fact, emerging immunotherapy data is changing how clinicians view early-stage disease and the opportunity to intervene …

What happens when a patient walks into your clinic and their diabetes simply doesn’t fit the usual mold? In many cases, clinicians rely on well-established categories like Type 1 or Type 2 diabetes. However, diagnosing atypical forms of diabetes is becoming increasingly important as more patients present with mixed or …

GLP-1 receptor agonists as adjunct therapy in type 1 diabetes are gaining attention as clinicians look for new ways to improve glycemic control. But is this approach a promising tool or a risky shortcut? As emerging evidence builds, providers must balance potential benefits with safety concerns and patient-specific factors. Table …

Continuous ketone monitoring for diabetes is emerging as one of the most intriguing developments in metabolic care. For decades, clinicians relied on periodic blood or urine tests to detect rising ketones. However, those methods often identify problems only after metabolic imbalance has already progressed. In contrast, newer sensor systems promise …

Continuous glucose monitoring was once reserved for endocrinology clinics. Today, integrating CGM into primary care is essential as guidelines recommend earlier and broader use in both type 1 and type 2 diabetes. Yet many clinicians still feel unsure about how to interpret reports or fit CGM into a busy visit. …

Imagine managing type 1 diabetes and still gaining weight despite careful insulin use, exercise, and carb counting. That’s the frustrating reality for many people living with T1D and obesity. While insulin is life-saving, it can also promote weight gain, making the balance between glucose control and healthy weight even harder. …

Artificial intelligence (AI) is transforming many aspects of diabetes care, and smart insulin management powered by AI is quickly becoming one of its most promising innovations. Tools that read continuous glucose monitor (CGM) data and suggest insulin changes are rapidly entering clinical use. But while these tools are powerful, they …